• XS
  • S
  • M
  • L
  • XL
  • S
  • M
  • L
  • Event Times (GMT+10)
  • Local Times (GMT+2)
Plenary Hall
Session Room 213
Session Room 219
Session Room 220
Session Room 216
Session Room 217
Poster Area
Networking Area
07:00 AM
08:00 AM
09:00 AM
10:00 AM
11:00 AM
12:00 PM
01:00 PM
02:00 PM
03:00 PM
04:00 PM
05:00 PM
06:00 PM
07:00 PM
Sponsored Breakfast Symposium
Plenary 4: Keynote Lecture Susan Shur-Fen Gau
OPEN: Exhibition & CINP Members' Lounge
Morning Coffee Break
Poster Session 3: Bipolar Disorders, OCD, PTSD, Variable
Medical Legalization of Psychedelics: An International Perspective
Symposium 8: From Molecular Mechanisms to Brain Circuitries: How Psychedelics are Reshaping Our Understanding of Neuropsychiatric and Behavioral Disorder Treatments
Symposium 9: The Role of Biomarkers in The Development of More Personalized and Effective Treatments for Psychiatric Disorders
Symposium 7: Susceptibility in the Developing Brain: Why the Timing of Insults and Sex Matter
Data Blitz 4: Depression treatment
Selected Colloquium 9: Recent Advances in Obsessive Compulsive Disorder (OCD)
Spotlight Session 4: Women in Neuropsychopharmacology
Featured Communication 4: Schizophrenia/Clinical
NbN Updates: NbN for patients & families (NbNpf); Different Dose, Different Pharmacology concept (DDDP)
Selected Colloquium 3: Targeting NMDA Receptors Mediate Neuron-Glia Interactions for the Treatment of Neuropsychiatric Disorders: From Basic Research to Application
Data Blitz 5: Psychedelic/ketamine-related
Selected Colloquium 8: Lithium: the latest news about the oldest drug in psychiatry
Lunch Break
Sponsored Lunch Symposium
Poster Session 4: Childhood & Adolescent Disorders, ADHD, Dementia, Epilepsy, Pain, Variable
Poster Session 5: Depression
Symposium 10: Adversity and altered states? The neurobiological signature of early life adversity on the brain, and relevance to psychoactive drug responses
Symposium 11: Adult neurogenesis or de-differentiation regulate hippocampus plasticity in health and disease
Symposium 12: Reformulation, omics-based biomarkers and health economic implications of ketamine in the treatment of depression
Campfire Session: I Was So Much Older Then: Reflections on Research for Early Career Researchers (LIMITED SEATS)
Selected Colloquium 4: Circuits driving drug taking: What insights for treatment do they hold?
Spotlight Session 5: Addiction and Mental Health
Afternoon Coffee Break
Featured Communication 5: Addiction/Cannabis
Spotlight Session 7: Frontiers of schizophrenia research in basic and clinical from JSNP and JSCNP
Spotlight Session 8: Recent advances in Alzheimer's Disease
Spotlight Session 6:
Between Passion and Pressure: Early Career Researchers Round Table
Data Blitz 6: Psychosis characterization
Outstanding Poster Presentation Session
Spotlight Session 9: Recent Advances in ADHD
Featured Communication 6: Steroids/Depression
Data Blitz 7: Schizophrenia-related
CINP General Assembly: CINP Members only
Selected Colloquium 1: Effects of Early Life Adversity on the Structure of Common Mental Disorders: Reimagining the Diathesis-Stress Model
Selected Colloquium 7: Re-Evaluating 'Older' Drugs for the Treatment of Mood Disorders; a Focus on MAOI's, Lithium and Psychedelics
CINP Members' Reception